Antiviral agents for the treatment of recurrent respiratory papillomatosis: A systematic review of the English-language literature

Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 6, 2007, Pages 863-869

  Chadha, Neil K ^a   James, Adrian L ^b  

^a TORBAY HOSPITAL   (United Kingdom)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ACICLOVIR; ALPHA2B INTERFERON; ANTIVIRUS AGENT; CIDOFOVIR; PROBENECID; RIBAVIRIN;

ADJUVANT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE FREE INTERVAL; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FATIGUE; FOLLOW UP; GLUCOSURIA; HEADACHE; HUMAN; LARYNX PAPILLOMATOSIS; NEPHROTOXICITY; NEUTROPENIA; PAPILLOMATOSIS; POLYURIA; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; REMISSION; RESPIRATORY PAPILLOMATOSIS; RETICULOCYTOSIS; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTIVIRAL AGENTS; CYTOSINE; HUMANS; INJECTIONS, INTRALESIONAL; NEOPLASM RECURRENCE, LOCAL; OTORHINOLARYNGOLOGIC NEOPLASMS; PAPILLOMA; PHOSPHONIC ACIDS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 34249655588     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2006.09.007     Document Type: Review

References (50)

1. Morgan A.H., and Zitsch R.P. Recurrent respiratory papillomatosis in children: a retrospective study of management and complications. Ear Nose Throat J 65 9 (1986) 19-28
2. Derkay C.S. Recurrent respiratory papillomatosis. Laryngoscope 111 1 (2001) 57-69
3. Kimberlin D.W. Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis. Antiviral Res 63 3 (2004) 141-151
4. Shykhon M., Kuo M., and Pearman K. Recurrent respiratory papillomatosis. Clin Otolaryngol Allied Sci 27 4 (2002) 237-243
5. Menzo S., Monachetti A., Trozzi C., et al. Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. J Virol 75 23 (2001) 11913-11919
6. Corbitt G., Zarod A.P., Arrand J.R., et al. Human papillomavirus (HPV) genotypes associated with laryngeal papilloma. J Clin Pathol 41 3 (1988) 284-288
7. Rabah R., Lancaster W.D., Thomas R., et al. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol 4 1 (2001) 68-72
8. Pou A.M., Rimell F.L., Jordan J.A., et al. Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol 104 10 Pt 1 (1995) 758-762
9. Silverberg M.J., Thorsen P., Lindeberg H., et al. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 101 4 (2003) 645-652
10. Kashima H.K., Shah F., Lyles A., et al. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 102 1 (1992) 9-13
11. Derkay C.S., Malis D.J., Zalzal G., et al. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 108 6 (1998) 935-937
12. Derkay C.S., and Darrow D.H. Recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 115 1 (2006) 1-11
13. Mehta DK. British National Formulary. 46th Edition. British Medical Association and Royal Pharmaceutical Society of Great Britain, London; September 2005.
14. Schraff S., Derkay C.S., Burke B., et al. American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 130 9 (2004) 1039-1042
15. Tasca R.A., McCormick M., and Clarke R.W. British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 70 7 (2006) 1183-1187
16. Chadha N.K., and James A.L. Adjuvant antiviral therapy for recurrent respiratory papillomatosis. Cochrane Database Syst Rev 4 (2005) CD005053
17. Oxford Centre for Evidence-based Medicine. Levels of evidence (2001). http://www.cebm.net/levels_of_evidence.asp#levels May. http://www.cebm.net/levels_of_evidence.asp#levels (accessed 17/3/2006).
18. Young J., Fry-Smith A., and Hyde C. Lung volume reduction surgery (LVRS) for chronic obstructive pulmonary disease (COPD) with underlying severe emphysema. Thorax 54 9 (1999) 779-789
19. Naiman A.N., Abedipour D., Ayari S., et al. Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections. Ann Otol Rhinol Laryngol 115 3 (2006) 175-181
20. Dikkers F.G. Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir-a prospective study. Eur Arch Otorhinolaryngol 263 5 (2006) 440-443
21. Lee A.S., and Rosen C.A. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis. J Voice 18 4 (2004) 551-556
22. Co J., and Woo P. Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 113 11 (2004) 859-862
23. Mandell D.L., Arjmand E.M., Kay D.J., et al. Intralesional cidofovir for pediatric recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 130 11 (2004) 1319-1323
24. Peyton Shirley W., and Wiatrak B. Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children?. Int J Pediatr Otorhinolaryngol 68 4 (2004) 413-418
25. Naiman A.N., Ceruse P., Coulombeau B., et al. Intralesional cidofovir and surgical excision for laryngeal papillomatosis. Laryngoscope 113 12 (2003) 2174-2181
26. Chhetri D.K., and Shapiro N.L. A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir. Arch Otolaryngol Head Neck Surg 129 10 (2003) 1081-1085
27. Pransky S.M., Albright J.T., and Magit A.E. Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope 113 9 (2003) 1583-1587
28. Akst L.M., Lee W., Discolo C., et al. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 129 8 (2003) 841-846
29. Milczuk H.A. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children. Otolaryngol Head Neck Surg 128 6 (2003) 788-794
30. El Hakim H., Waddell A.N., and Crysdale W.S. Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir. J Otolaryngol 31 6 (2002) 333-335
31. Bielamowicz S., Villagomez V., Stager S.V., et al. Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort. Laryngoscope 112 4 (2002) 696-699
32. Chhetri D.K., Blumin J.H., Shapiro N.L., et al. Office-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir. Otolaryngol Head Neck Surg 126 6 (2002) 642-648
33. Armbruster C., Kreuzer A., Vorbach H., et al. Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon α-2b. Eur Respir J 17 4 (2001) 830-831
34. Balauff A., Sira J., Pearman K., et al. Successful ribavirin therapy for life-threatening laryngeal papillomatosis post liver transplantation. Pediatr Transplant 5 2 (2001) 142-144
35. Van Valckenborgh I., Wellens W., De Boeck K., et al. Systemic cidofovir in papillomatosis. Clin Infect Dis 32 3 (2001) E62-E64
36. Pransky S.M., Brewster D.F., Magit A.E., et al. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 126 10 (2000) 1239-1243
37. Wilson W.R., Hashemiyoon R., and Hawrych A. Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report. Ear Nose Throat J 79 4 (2000) 236-238 240
38. Dancey D.R., Chamberlain D.W., Krajden M., et al. Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature. Chest 118 4 (2000) 1210-1214
39. Pransky S.M., Magit A.E., Kearns D.B., et al. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 125 10 (1999) 1143-1148
40. Snoeck R., Wellens W., Desloovere C., et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol 54 3 (1998) 219-225
41. Kiroglu M., Cetik F., Soylu L., et al. Acyclovir in the treatment of recurrent respiratory papillomatosis: a preliminary report. Am J Otolaryngol 15 3 (1994) 212-214
42. Endres D.R., Bauman N.M., Burke D., et al. Acyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study. Ann Otol Rhinol Laryngol 103 4 Pt 1 (1994) 301-305
43. McGlennen R.C., Adams G.L., Lewis C.M., Faras A.J., and Ostrow R.S. Pilot trial of ribavirin for the treatment of laryngeal papillomatosis. Head Neck 15 6 (1993) 504-512 discussion 512-3
44. Lopez Aguado D., Perez Pinero B., Betancor L., et al. Acyclovir in the treatment of laryngeal papillomatosis. Int J Pediatr Otorhinolaryngol 21 3 (1991) 269-274
45. Ostrow R.S., Forslund K.M., McGlennen R.C., et al. Ribavirin mitigates wart growth in rabbits at early stages of infection with cottontail rabbit papillomavirus. Antiviral Res 17 2 (1992) 99-113
46. Wachsman M., Petty B.G., Cundy K.C., et al. Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects. Antiviral Res 29 2-3 (1996) 153-161
47. Cundy K.C., Lynch G., and Lee W.A. Bioavailability and metabolism of cidofovir following topical administration to rabbits. Antiviral Res 35 2 (1997) 113-122
48. Naiman A.N., Roger G., Gagnieu M.C., et al. Cidofovir plasma assays after local injection in respiratory papillomatosis. Laryngoscope 114 7 (2004) 1151-1156
49. Derkay C. Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks. Int J Pediatr Otorhinolaryngol 69 11 (2005) 1465-1467
50. Armstrong L.R., Derkay C.S., and Reeves W.C. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force. Arch Otolaryngol Head Neck Surg 125 7 (1999) 743-748